Search - tctmd.com

Displaying 441 - 460 of 635

Sort: Relevancy | Date

Presentation TCT 2017

TENDYNE: 1-Year Outcomes of Transcatheter MV Replacement in Patients With Severe Mitral Regurgitation

Presenter: Francesco Maisano, David W.M. Muller

November 01, 2017

Presentation TCT 2017

INTREPID: 30-Day Outcomes of Transcatheter MV Replacement in Patients With Severe Mitral Regurgitation

Presenter: Francesco Maisano, Paul Sorajja

November 01, 2017

Presentation TCT 2017

Topic 1: Anticoagulation After TAVR Should Now be Standard of Care CON!

Presenter: Adrian P. Banning, Ted Feldman, Bernard Prendergast

November 01, 2017

Presentation TCT 2017

Post-TAVR Valve Thickening: Current Data and Open Questions

Presenter: Jonathon A. Leipsic, Maurice E. Sarano, Hasan Jilaihawi

November 01, 2017

Presentation TCT 2017

Topic 1: Anticoagulation After TAVR Should Now be Standard of Care PRO!

Presenter: Adrian P. Banning, Ted Feldman, Raj Makkar

November 01, 2017

Presentation TCT 2017

Venezuela Presents: A Complex Vascular Complication During TAVI - Solution and Lessons Learned

Presenter: Waqar H. Ahmed, Oscar A. Mendiz, Carlos D Calderas

November 01, 2017

Presentation TCT 2017

Approval Pathways for Transcatheter Mitral and Tricuspid Valve Therapies

Presenter: Steven F. Bolling, John C Laschinger, Bernard Vasseur

October 31, 2017

Presentation TCT 2017

Transcatheter Mitral Valve Replacement Device Trials: Regulatory Approval Trial Design Considerations

Presenter: Steven F. Bolling, John C Laschinger, Martin B. Leon

October 31, 2017

Presentation TCT 2017

Transcatheter FMR Mitral Valve Repair Device Trials for Regulatory Approval Post-COAPT: Lessons Learned, Future Directions

Presenter: Steven F. Bolling, John C Laschinger, Ori Ben-Yehuda

October 31, 2017

Presentation TCT 2017

FDA Perspectives on TAVR Label Expansion Using Real-World Evidence, Valve Degeneration, and Embolic Protection Devices

Presenter: Martin B. Leon, Changfu Wu, John C Laschinger

October 31, 2017

Presentation TCT 2017

Valve Degeneration and Leaflet Mobility Considerations: Assessing Clinical Relevance

Presenter: Martin B. Leon, Changfu Wu, Lars Sondergaard

October 31, 2017

Presentation TCT 2017

Embolic Protection Devices For TAVR Procedures: Lessons Learned From SENTINEL and Other Experiences

Presenter: Martin B. Leon, Changfu Wu

October 31, 2017

Presentation TCT 2017

Industry Perspective on Real-World Evidence for TAVR Outcomes Where are the Opportunities?

Presenter: Martin B. Leon, Changfu Wu, Larry L. Wood

October 31, 2017

Presentation TCT 2017

Case #2: Double Aortic and Mitral Transcatheter Valve Replacement Using Innovative Bioprostheses

Presenter: João AB Brum Silveira, Marcelo Jose de Carvalho Cantarelli, Henrique B. Ribeiro

October 31, 2017

Presentation TCT 2017

TCT 104: Initial Pre-clinical and Clinical Use of Mechanical Intracardiac Echocardiography System With 3D Viewing, Color Doppler, and Side-Viewing Capabilities

Presenter: Brij Maini, Petr Neuzil, Brian Courtney, MD

October 31, 2017

Presentation TCT 2017

TCT 40: Outcome Of Patients Undergoing Trans-Catheter Implantation of Aortic Valve With Previous Mitral Valve Prosthesis (Optimal Study)

Presenter: Jean-Claude Laborde, Eric Van Belle, Luca Baldetti, MD

October 31, 2017

Presentation TCT 2017

TCT 56: Transcatheter Mitral Valve Repair in Patients With Functional Mitral Regurgitation One-Year Outcomes from the Multicenter CE Trial

Presenter: Karl-Heinz Kuck, Nicolo Piazza, Francesco Maisano

October 31, 2017

Presentation TCT 2017

Case #1: Fatal Embolization During Left Atrial Appendage Percutaneous Occlusion in a TAVR Patient

Presenter: João AB Brum Silveira, Marcelo Jose de Carvalho Cantarelli, Antonio Fiarresga

October 31, 2017

Presentation TCT 2017

TCT 103: Long-Term Outcomes of Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: A 16 Year Study

Presenter: Brij Maini, Petr Neuzil, Christopher Capps, MD

October 31, 2017

Presentation TCT 2017

TCT 39: Clinical Outcomes in SURTAVI Based on Revascularization Stratification

Presenter: Jean-Claude Laborde, Eric Van Belle, Lars Sondergaard

October 31, 2017

Advertisement

TENDYNE: 1-Year Outcomes of Transcatheter MV Replacement in Patients With Severe Mitral Regurgitation

INTREPID: 30-Day Outcomes of Transcatheter MV Replacement in Patients With Severe Mitral Regurgitation

Topic 1: Anticoagulation After TAVR Should Now be Standard of Care CON!

Post-TAVR Valve Thickening: Current Data and Open Questions

Topic 1: Anticoagulation After TAVR Should Now be Standard of Care PRO!

Venezuela Presents: A Complex Vascular Complication During TAVI - Solution and Lessons Learned

Approval Pathways for Transcatheter Mitral and Tricuspid Valve Therapies

Transcatheter Mitral Valve Replacement Device Trials: Regulatory Approval Trial Design Considerations

Transcatheter FMR Mitral Valve Repair Device Trials for Regulatory Approval Post-COAPT: Lessons Learned, Future Directions

FDA Perspectives on TAVR Label Expansion Using Real-World Evidence, Valve Degeneration, and Embolic Protection Devices

Valve Degeneration and Leaflet Mobility Considerations: Assessing Clinical Relevance

Embolic Protection Devices For TAVR Procedures: Lessons Learned From SENTINEL and Other Experiences

Industry Perspective on Real-World Evidence for TAVR Outcomes Where are the Opportunities?

Case #2: Double Aortic and Mitral Transcatheter Valve Replacement Using Innovative Bioprostheses

TCT 104: Initial Pre-clinical and Clinical Use of Mechanical Intracardiac Echocardiography System With 3D Viewing, Color Doppler, and Side-Viewing Capabilities

TCT 40: Outcome Of Patients Undergoing Trans-Catheter Implantation of Aortic Valve With Previous Mitral Valve Prosthesis (Optimal Study)

TCT 56: Transcatheter Mitral Valve Repair in Patients With Functional Mitral Regurgitation One-Year Outcomes from the Multicenter CE Trial

Case #1: Fatal Embolization During Left Atrial Appendage Percutaneous Occlusion in a TAVR Patient

TCT 103: Long-Term Outcomes of Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: A 16 Year Study

TCT 39: Clinical Outcomes in SURTAVI Based on Revascularization Stratification

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content